Loading article...
Tokyo, Japan and Cambridge, UK, 1 May 2026 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended 31 March 2026. The full report can be found here.
Tokyo, Japan and Cambridge, UK, 1 May 2026 Nxera Pharma (the Company or Nxera; TSE: 4565) provides an update on operational activities and reports its consolidated results for the first quarter ended… [+11472 chars]
Continue reading on GlobeNewswire
Read Full Article